MedTrace Logo

Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine

NCT00541892 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2015-05-20

No results posted yet for this study

Summary

The purpose of this study is to determine if a new medium with no human serum albumine added is as good as the media conventionally used for IVF/ICSI.

Conditions

Interventions

OTHER

Medium with no human serum albumine added

See above

OTHER

Conventional medium

See above

Sponsors & Collaborators

  • Cellcura AS

    collaborator INDUSTRY

  • Vekst i Grenland

    collaborator UNKNOWN

  • Innovation Norway

    collaborator UNKNOWN

  • Sykehuset Telemark

    lead OTHER_GOV

Principal Investigators

  • Jarl Kahn, Dr. Med · Fertilitetsklinikken Sør

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00541892 on ClinicalTrials.gov